127 related articles for article (PubMed ID: 3774591)
1. Intraventricular administration of arginine vasopressin suppresses prolactin release via a dopaminergic mechanism.
DePaolo LV; Berardo PV; Carrillo AJ
Peptides; 1986; 7(3):541-4. PubMed ID: 3774591
[TBL] [Abstract][Full Text] [Related]
2. Mediation of the stress-induced prolactin release by hypothalamic histaminergic neurons and the possible involvement of vasopressin in this response.
Kjaer A; Knigge U; Olsen L; Vilhardt H; Warberg J
Endocrinology; 1991 Jan; 128(1):103-10. PubMed ID: 1986913
[TBL] [Abstract][Full Text] [Related]
3. Opioid and dopamine involvement in prolactin release induced by arginine vasotocin and vasopressin in the male rat.
Blask DE; Vaughan MK; Champney TH; Johnson LY; Vaughan GM; Becker RA; Reiter RJ
Neuroendocrinology; 1984 Jan; 38(1):56-61. PubMed ID: 6694785
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical effects of oxytocin and vasopressin on basal prolactin secretion and the estrogen-induced prolactin surge.
Mai LM; Pan JT
Life Sci; 1990; 47(14):1243-51. PubMed ID: 2123015
[TBL] [Abstract][Full Text] [Related]
5. Intracerebroventricular injection of arginine-vasopressin V1 receptor antagonist attenuates the surge of luteinizing hormone and prolactin secretion in proestrous rats.
Funabashi T; Aiba S; Sano A; Shinohara K; Kimura F
Neurosci Lett; 1999 Jan; 260(1):37-40. PubMed ID: 10027694
[TBL] [Abstract][Full Text] [Related]
6. Do the circulating neurohypophysial hormones affect basal or stress induced prolactin (PRL) release in male rats?
Jurcovicová J; Dobrakovová M; Oprsalová Z; Jezová D; Makara GB; Kvetnanský R
Endocr Regul; 1991 Sep; 25(3):159-63. PubMed ID: 1764605
[TBL] [Abstract][Full Text] [Related]
7. Involvement of vasopressin in histamine- and stress-induced prolactin release: permissive, mediating or potentiating role?
Kjaer A; Knigge U; Vilhardt H; Warberg J
Neuroendocrinology; 1993; 57(2):314-21. PubMed ID: 8510805
[TBL] [Abstract][Full Text] [Related]
8. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
Mogg RJ; Samson WK
Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
[TBL] [Abstract][Full Text] [Related]
9. Central injections of arginine vasopressin prolong extinction of active avoidance.
Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
[TBL] [Abstract][Full Text] [Related]
10. Histaminergic regulation of prolactin secretion: involvement of tuberoinfundibular dopaminergic neurons.
Knigge U; Matzen S; Warberg J
Neuroendocrinology; 1988 Aug; 48(2):167-73. PubMed ID: 2975768
[TBL] [Abstract][Full Text] [Related]
11. Central vasopressin pretreatment sensitizes phosphoinositol hydrolysis in the rat septum.
Lebrun CJ; Gruber MG; Meister M; Unger T
Brain Res; 1990 Oct; 531(1-2):167-72. PubMed ID: 1963099
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma prolactin levels in ovariectomized thyroidectomized rats treated with estrogen.
Pan JT; Chen CW
Endocrinology; 1990 Jun; 126(6):3146-52. PubMed ID: 1972060
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.
Bodnar RJ; Truesdell LS; Nilaver G
Peptides; 1985; 6(4):621-6. PubMed ID: 4070021
[TBL] [Abstract][Full Text] [Related]
14. The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man.
Ho KY; Smythe GA; Lazarus L
Clin Endocrinol (Oxf); 1985 Jul; 23(1):7-16. PubMed ID: 3928213
[TBL] [Abstract][Full Text] [Related]
15. Relation between luteinizing hormone and prolactin pulses in ovariectomized rats with or without dopamine inhibition.
Pohl CR; Weiner RI; Smith MS
Endocrinology; 1988 Sep; 123(3):1591-7. PubMed ID: 3402398
[TBL] [Abstract][Full Text] [Related]
16. Central inhibitory action of TRH on prolactin secretion in the rat.
Ohta H; Kato Y; Matsushita N; Shimatsu A; Kabayama Y; Imura H
Proc Soc Exp Biol Med; 1985 May; 179(1):9-12. PubMed ID: 3921974
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
Rossi NF
Am J Physiol; 1998 Oct; 275(4):E687-93. PubMed ID: 9755089
[TBL] [Abstract][Full Text] [Related]
18. Domperidone stimulates prolactin secretion in rats with complete destruction of the mediobasal hypothalamus.
Kiem DT; Nagy GM; Barna I; Makara GB
Brain Res Bull; 1997; 44(2):151-4. PubMed ID: 9292204
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic blood flow autoregulation remains unaltered following surgical and pharmacological blockade of central vasopressin.
Sandor P; Petty M; de Jong W; Palkovits M; de Wied D
Brain Res; 1991 Dec; 566(1-2):212-8. PubMed ID: 1814538
[TBL] [Abstract][Full Text] [Related]
20. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats.
Maione S; Vitagliano S; Berrino L; Lampa E; Rossi F
Neuropharmacology; 1992 Apr; 31(4):403-7. PubMed ID: 1355901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
